Salt enhances responsiveness of terminal aortic vascular bed to sympathetic activity

European Journal of Clinical Pharmacology

Volumn 52, Issue 5, 1997, Pages 343-349

  Shimamoto, H ^a   Shimamoto, Y ^a  

^a PIA Nakamura Hospital   (Japan)

Author keywords

Hypertension, benidipine, haemodynamics, sympathetic tone; Sodium

Indexed keywords

BENIDIPINE; PRAZOSIN;

ADRENERGIC SYSTEM; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ESSENTIAL HYPERTENSION; FEMALE; HEMODYNAMICS; HUMAN; INTRAGASTRIC DRUG ADMINISTRATION; MALE; PRIORITY JOURNAL; SALT INTAKE; SYMPATHETIC TONE; VASCULAR RESISTANCE;

AGED; AORTA; ARGININE VASOPRESSIN; CALCIUM CHANNEL BLOCKERS; DIET, SODIUM-RESTRICTED; DIHYDROPYRIDINES; FEMALE; HEMODYNAMIC PROCESSES; HUMANS; HYPERTENSION; MALE; MESENTERIC ARTERIES; NOREPINEPHRINE; PRAZOSIN; RENAL ARTERY; SODIUM CHLORIDE, DIETARY; SYMPATHETIC NERVOUS SYSTEM; SYMPATHOLYTICS; VASCULAR RESISTANCE;

EID: 0030820778     PISSN: 00316970     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002280050299     Document Type: Article

References (31)

1. Freis ED (1976) Salt volume and prevention of hypertension. Circulation 53: 589-595
2. Shimamoto H, Shimamoto Y (1990) Time course of haemodynamic responses to sodium in elderly hypertensive patients. Hypertension 16: 387-397
3. Shimamoto H, Shimamoto Y (1992) Terminal aortic response to sodium intake is the major determinant of total peripheral resistance in elderly hypertensives. J Hum Hypertens 6: 353-358
4. Shimamoto H, Shimamoto Y (1992) Plasma norepinephrine is a major determinant of haemodynamic alterations with sodium loading. J Hypertens 10: 855-860
5. Campese VM (1988) Effects of calcium antagonists on deranged modulation of the renal function curve in salt-sensitive patients with essential hypertension. Am J Cardiol 62: 85G-91G
6. Karasawa A, Kubo K (1988) Calcium antagonistic effects and the in vitro duration of actions of KW-3049, new 1,4-dihydropyridine derivative, in isolated canine coronary arteries. Jpn J Pharmacol 47: 35-44
7. Hobbs DC, Twomey TM, Palmer RF (1978) Pharmacokinetics of prazosin in man. J Clin Pharmacol 18: 402-406
8. Shimamoto H, Shimamoto Y, Kito H, Kawazoe K, Fujita T, Okamoto M (1992) Doppler echocardiographic measurement of cardiac output in man using mitral annulus method. J Clin Ultrasound 20: 263-270
9. Shimamoto H, Kito H, Kawazoe K, Fujita T, Shimamoto Y (1992) Quantitative pulsed Doppler measurement of arterial blood flows in humans. Vasc Surg 26: 408-414
10. Hatle L, Angelsen B (1985) Blood velocity measurements using the Doppler effect of backscattered ultrasound. In: Hatle L, Angelsen B (eds) Doppler ultrasound in cardiology, 2nd edn. Lea and Fehiger, Philadelphia, pp 32-73
11. Nakamura T. Moriyasu F, Ban N, Nishida O, Tamada T, Kawasaki T, Sakai M, Uchino H (1989) Quantitative measurement of abdominal arterial blood flow using image-directed Doppler ultrasonography: superior mesenteric, splenic, and common hepatic arterial blood flow in normal adults. J Clin Ultrasound 17: 261-268
12. Tsuji U, Nakanishi T, Nakai K, Shiomi J, Funahashi S (1988) Liquid-chromatographic measurement of catecholamines in plasma and urine using HLC-8030. Kiki Shiyaku 11: 635-641
13. 18 silica column. Folia Endocrinol 61: 724-736
14. Rovvell LB (1986) Control of individual vascular beds: splanchnic and renal circulations. In: Rowell LB (ed) Human circulation regulation during physical stress. Oxford University Press, New York, pp 78-95
15. Rowell LB (1986) Cutaneous and skeletal muscle circulations. In: Rowell LB (ed) Human circulation regulation during physical stress. Oxford University Press, New York, pp 96-116
16. Campese VM, Romoff MS, Levitan D, Saglikes Y, Friedler RM, Massry SG (1982) Abnormal relationship between sodium intake and sympathetic nervous system activity in salt-sensitive patients with essential hypertension. Kidney Int 21: 371-378
17. Koolen MI, van Brummelen P (1984) Adrenergic activity and peripheral haemodynamics in relation to sodium sensitivity in patients with essential hypertension. Hypertension 6: 820-825
18. Shimamoto H, Iriuchijima J (1987) Haemodynamic characteristics of conscious deoxycorticosterone acetate hypertensive rats. Jpn J Physiol 37: 243-254
19. Altura BM, Altura BT (1977) Vascular smooth muscle and neurohypophyseal hormones. Fed Proc 36: 1853-1860
20. Monos E, Cox RH, Peterson LH (1978) Direct effect of physiological doses of arginine vasopressin on the arterial wall in vivo. Am J Physiol 234: H167-H172
21. Morton JJ, Padfield PL (1986) Vasopressin and hypertension in man. J Cardiovasc Pharmacol 8: S101-S106
22. Montani J-P, Liard J-F, Schoun J, Möhring J (1980) Haemodynamic effects of exogenous and endogenous vasopressin at low plasma concentrations in conscious dogs. Circ Res 47: 346-355
23. Bartelstone HJ, Nasmyth PA (1965) Vasopressin potentiation of catecholamine actions in dog, rat, cat, and rat aortic strip. Am J Physiol 208: 754-762
24. Erwald R, Wiechel KL (1978) Effect of vasopressin on central and splanchnic haemodynamics in awake man. Acta Chir Scand 144: 347-358
25. Charocopos F, Hatzinikolaou P, North WG, Gavras H (1982) Systemic and regional haemodynamic effects of endogenous vasopressin stimulation in rats. Am J Physiol 243: H560-H565
26. Heyndrickx GR, Boettcher DH, Vatner SF (1976) Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol 231: 1579-1587
27. Gavras I, Gavras H (1990) Role of vasopressin in hypertensive disorders. In: Laragh JH, Brenner BM (eds) Hypertension: pathophysiology, diagnosis, and management. Raven Press, New York, pp 779-789
28. Daniel FE, Shi AG, Wang ZL, Guan YY, Hoo K, Cragoe EJ, Kwan CY (1991) Alpha-adrenoceptors in vascular smooth muscle: all is not well. Blood Vessels 28: 104-114
29. Shimamoto H, Bourreau J-P, Kwan CY, Daniel EE (1992) Amplification of alpha adrenergic vasoconstriction in canine isolated mesenteric artery and vein. J Pharmacol Exp Ther 260: 1119-1127
30. Gavras H (1986) How does salt raise blood pressure? A hypothesis. Hypertension 8: 83-88
31. 2-adrenoceptors: evidence for and against a further subdivision. Pharmacol Ther 44: 241-284